Department of Dermatology, Rutgers New Jersey Medical School, Newark, NJ, 07103, USA.
Am J Clin Dermatol. 2023 May;24(3):375-380. doi: 10.1007/s40257-023-00757-9. Epub 2023 Jan 25.
Muir-Torre syndrome (MTS) is a rare autosomal dominant genetic condition resulting from microsatellite instability which is caused by mutations in DNA mismatch repair genes. This disorder predisposes individuals to skin tumors and visceral malignancies and may be precipitated in immunocompromised or transplant patients. MTS requires close cancer surveillance for the patient and family because of the tendency to develop aggressive internal malignancies and sebaceous carcinoma. Immunohistochemistry and or genetic testing can confirm the diagnosis of MTS. This review offers an update to the guidelines, diagnosis, and management of MTS while offering a unique perspective on an important but lesser-known syndrome.
穆尔- Torre 综合征(MTS)是一种罕见的常染色体显性遗传疾病,由 DNA 错配修复基因的突变引起的微卫星不稳定性导致。这种疾病使个体易患皮肤肿瘤和内脏恶性肿瘤,并可能在免疫功能低下或移植患者中加重。由于倾向于发展侵袭性内部恶性肿瘤和皮脂腺癌,MTS 需要对患者和家属进行密切的癌症监测。免疫组织化学和/或基因检测可确认 MTS 的诊断。本综述提供了 MTS 指南、诊断和管理的更新,同时对一个重要但鲜为人知的综合征提供了独特的视角。